Apogem Capital’s Confluent CFLT Stock Holding History

Apogem Capital’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,773	Closed	-$422K	–	18
2022 Q3	$422K	Buy	17,773 +2,147	+14%	+$57.8K	0.42%	79
2022 Q2	$363K	Buy	+15,626	New	+$421K	0.33%	95

Other funds holding CFLT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Apogem Capital's CFLT Position: Q4 2022 in Review

Apogem Capital sold out of Confluent (CFLT) in Q4 2022, closing a stake of 17,773 shares — an estimated $422K sold.

Apogem Capital first reported a position in CFLT in Q2 2022 and held it in 2 quarters. The position peaked at $422K in Q3 2022. 247 funds tracked by Wall St. Rank hold CFLT as of Q4 2022.

Apogem Capital reported no remaining Confluent position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 17,773 Confluent shares in Q4 2022, an estimated $422K.
Apogem Capital first reported a position in Confluent in Q2 2022 and held it in 2 quarters.
Apogem Capital's Confluent position peaked at $422K in Q3 2022.
247 funds tracked by Wall St. Rank held Confluent as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.